118 related articles for article (PubMed ID: 34016989)
1. NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.
Ganz PA; Cecchini RS; Fehrenbacher L; Geyer CE; Rastogi P; Crown JP; Thirlwell MP; Ellison DM; Boileau JF; Flynn PJ; Jeong JH; Mamounas EP; Wolmark N
NPJ Breast Cancer; 2021 May; 7(1):55. PubMed ID: 34016989
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
Ruddy KJ; Guo H; Barry W; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Overmoyer BA; Hudis C; Krop IE; Burstein HJ; Winer EP; Partridge AH; Tolaney SM
Breast Cancer Res Treat; 2015 Jun; 151(3):589-96. PubMed ID: 25981899
[TBL] [Abstract][Full Text] [Related]
3. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Fehrenbacher L; Cecchini RS; Geyer CE; Rastogi P; Costantino JP; Atkins JN; Crown JP; Polikoff J; Boileau JF; Provencher L; Stokoe C; Moore TD; Robidoux A; Flynn PJ; Borges VF; Albain KS; Swain SM; Paik S; Mamounas EP; Wolmark N
J Clin Oncol; 2020 Feb; 38(5):444-453. PubMed ID: 31821109
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.
Chumsri S; Li Z; Serie DJ; Mashadi-Hossein A; Colon-Otero G; Song N; Pogue-Geile KL; Gavin PG; Paik S; Moreno-Aspitia A; Perez EA; Thompson EA
J Clin Oncol; 2019 Dec; 37(35):3425-3435. PubMed ID: 31622131
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.
Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W
PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
Ganz PA; Romond EH; Cecchini RS; Rastogi P; Geyer CE; Swain SM; Jeong JH; Fehrenbacher L; Gross HM; Brufsky AM; Flynn PJ; Wahl TA; Seay TE; Wade JL; Biggs DD; Atkins JN; Polikoff J; Zapas JL; Mamounas EP; Wolmark N
J Clin Oncol; 2017 Dec; 35(35):3942-3948. PubMed ID: 29072977
[TBL] [Abstract][Full Text] [Related]
7. Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831.
Pogue-Geile KL; Song N; Serie DJ; Wang Y; Gavin PG; Kim RS; Tanaka N; Fumagalli D; Taniyama Y; Li Z; Rastogi P; Swain SM; Mamounas EP; Geyer CE; Wolmark N; Lucas PC; Paik S; Thompson EA
JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa058. PubMed ID: 33241186
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea.
Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF
J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811
[TBL] [Abstract][Full Text] [Related]
9. The risk of premature menopause induced by chemotherapy for early breast cancer.
Lower EE; Blau R; Gazder P; Tummala R
J Womens Health Gend Based Med; 1999 Sep; 8(7):949-54. PubMed ID: 10534297
[TBL] [Abstract][Full Text] [Related]
10. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
Lambertini M; Campbell C; Bines J; Korde LA; Izquierdo M; Fumagalli D; Del Mastro L; Ignatiadis M; Pritchard K; Wolff AC; Jackisch C; Lang I; Untch M; Smith I; Boyle F; Xu B; Barrios CH; Baselga J; Moreno-Aspitia A; Piccart M; Gelber RD; de Azambuja E
J Natl Cancer Inst; 2019 Jan; 111(1):86-94. PubMed ID: 29878225
[TBL] [Abstract][Full Text] [Related]
12. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
Partridge A; Gelber S; Gelber RD; Castiglione-Gertsch M; Goldhirsch A; Winer E
Eur J Cancer; 2007 Jul; 43(11):1646-53. PubMed ID: 17512721
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
Brincker H; Rose C; Rank F; Mouridsen HT; Jakobsen A; Dombernowsky P; Panduro J; Andersen KW
J Clin Oncol; 1987 Nov; 5(11):1771-8. PubMed ID: 3316514
[TBL] [Abstract][Full Text] [Related]
14. The menopausal transition--endocrinology.
Burger H
J Sex Med; 2008 Oct; 5(10):2266-73. PubMed ID: 18624962
[TBL] [Abstract][Full Text] [Related]
15. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
Abusief ME; Missmer SA; Ginsburg ES; Weeks JC; Partridge AH
Cancer; 2010 Feb; 116(4):791-8. PubMed ID: 20052714
[TBL] [Abstract][Full Text] [Related]
16. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women.
Guthrie JR; Dennerstein L; Hopper JL; Burger HG
Obstet Gynecol; 1996 Sep; 88(3):437-42. PubMed ID: 8752255
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole.
Krekow LK; Hellerstedt BA; Collea RP; Papish S; Diggikar SM; Resta R; Vukelja SJ; Holmes FA; Reddy PK; Asmar L; Wang Y; Fox PS; Peck SR; O'Shaughnessy J
J Clin Oncol; 2016 May; 34(14):1594-600. PubMed ID: 26884554
[TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
Poikonen P; Saarto T; Elomaa I; Joensuu H; Blomqvist C
Eur J Cancer; 2000 Jan; 36(1):43-8. PubMed ID: 10741293
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer.
Kiess AP; McArthur HL; Mahoney K; Patil S; Morris PG; Ho A; Hudis CA; McCormick B
Cancer; 2012 Apr; 118(8):1982-8. PubMed ID: 21887681
[TBL] [Abstract][Full Text] [Related]
20. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles.
Harlow BL; Wise LA; Otto MW; Soares CN; Cohen LS
Arch Gen Psychiatry; 2003 Jan; 60(1):29-36. PubMed ID: 12511170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
